Related Experiment Videos
[A clinical study on gentamicin in the field of surgery]
Abstract:
Gentamicin (GM), one of the amino-glucosides, was administered intramuscularly to 27 patients with Pseudomonas and/or other antibiotics resistant infections. The clinical evaluation of the results obtained was classified excellent in 1 case good 6, fair 8, none 11 and indeterminate 1, the effectiveness accounting for 57.7 percent. Satisfactory results were noted in wound infections, peritonitis and urinary tract infections. Among untoward side effects, an elevation in GOT and GPT values was observed in 6 cases, an elevation of BUN value in 1, proteinuria in 1 and hematuria in 1. However, it is difficult to conclude that those side effects were attributable to GM itself because blood transfusion or combined therapy with anti-cancer agents was conducted in these cases during the GM therapy.
Insights
Gentamicin (GM) showed 57.7% effectiveness in treating antibiotic-resistant infections, with satisfactory results in wound, peritonitis, and urinary tract infections. Potential side effects were observed but difficult to attribute solely to GM.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Medicine
Context:
- Pseudomonas and other antibiotic-resistant infections pose significant treatment challenges.
- Aminoglycoside antibiotics, such as Gentamicin, are often considered for severe bacterial infections.
- Evaluating the efficacy and safety of Gentamicin in a real-world clinical setting is crucial.
Purpose:
- To assess the clinical effectiveness of intramuscular Gentamicin in patients with difficult-to-treat bacterial infections.
- To identify specific infection types where Gentamicin demonstrated satisfactory outcomes.
- To monitor and report adverse events potentially associated with Gentamicin therapy.
Summary:
- Intramuscular Gentamicin was administered to 27 patients with infections resistant to other antibiotics.
- Overall effectiveness was 57.7%, with notable success in wound, peritonitis, and urinary tract infections.
- Adverse events including elevated liver enzymes and kidney function markers were noted but causality to Gentamicin was uncertain due to confounding factors.
Impact:
- This study provides valuable data on Gentamicin's real-world effectiveness for resistant infections.
- Findings can inform clinical decision-making regarding Gentamicin use in specific infection types.
- Highlights the need for careful monitoring and consideration of co-therapies when assessing Gentamicin's safety profile.